CGEM EBITDA Growth
Cullinan Therapeutics Inc · EBITDA Growth
CGEM EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-1.00%period ending
CGEM TTM EBITDA YoY % (-171.51% → -1.00%)
Year-over-year change
High-resolution chart · PNG
CGEM ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -1.0022% | |
| -26.0486% | |
| -31.3583% | |
| -35.8302% | |
| -26.1663% | |
| -15.9925% | |
| 4.229% | |
| 2.7501% | |
| -11.6408% | |
| -1.5014% | |
| -38.7032% | |
| -24.9148% | |
| -20.0949% | |
| -49.4912% | |
| -86.4758% | |
| -110.0139% | |
| -119.0711% | |
| -89.8634% | |
| -11.9556% | |
| -73.0826% | |
| -76.5969% | |
| -136.3826% | |
| -171.5122% |